Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
Status:
Completed
Trial end date:
2020-06-18
Target enrollment:
Participant gender:
Summary
To see if megestrol acetate plus Levonorgestrel-releasing intrauterine system (LNG-IUS) will
not be inferior to returning the endometrial tissue to a normal state than megestrol acetate
alone in patients with early endometrial cancer.